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The CNS melanocortin (MC) and the autonomic nervous (ANS) system represent key regulators of energy
homeostasis. In this issue, Rossi et al. (2011) dissect metabolic functions of MC4 receptors based on
anatomic localization within the ANS by re-expressing MC4R subpopulations in cholinergic or brainstem
neurons of MC4R-KO mice.In 1848, the French physiologist Claude
Bernard envisioned that hepatic glucose
production was under the control of auto-
nomic nerves. After showing this in rabbits
(Bernard, 1850), numerous studies have
confirmed the essential role of the auto-
nomic nervous system (ANS) in glucose,
energy, and lipid metabolism. However,
our insights into the mechanisms that
fine tune the balance between the two
main components of the ANS, i.e., its
sympathetic and parasympathetic
branch, remain poorly understood. In this
issue, Rossi et al. (2011) use advanced
LoxP-Cre tools to rescue melanocortin
(MC) signaling in distinct subpopulations
of ANS motor neurons in melanocortin 4
receptor null (MC4R-KO) mice (Figure 1).
Their advanced genetic dissection studies
elegantly reveal how the preganglionic
sympathetic and parasympathetic
neurons are under direct control by the
MC system and exert well-defined differ-
ential roles in the central control of energy
and glucose metabolism.
MC signaling plays an important role in
energy metabolism, as clearly evidenced
by the fact that MC4R deficiency repre-
sents the commonest known monogenic
cause of human obesity. Rossi and
colleagues used loxP-modified null Mc4r
alleles (loxTB MC4R) to genetically
dissect the specific role of MC signaling
in sympathetic versus parasympathetic
preganglionic neurons. This was achieved
by either the general re-expression of
MC4R in all cholinergic neurons including
brainstem and spinal cord autonomic mo-
torneurons (loxTB MC4R, ChAT-Cre), or
by specifically re-expressing MC4Rs
only in autonomic control neurons, in-
cluding the parasympathetic motor
neurons in the dorsal motor nucleus ofthe vagus (loxTB MC4R and Phox2b-
Cre), but excluding the sympathetic
motorneurons in the spinal cord. Due to
the lack of suitably specific sympathetic
or spinal cord neuronal Cre mouse
models, the phenotype of MC4R re-
expression in only sympathetic motor
neurons of MC4R null mice was indirectly
deduced by comparing and ‘‘subtracting’’
the metabolic phenotypes of the general
and brainstem MC4R rescue models.
Re-expression of MC4R in cholinergic
neurons resulted in a 10% decrease of
body weight, lowered adiposity, and
a significant increase of energy expendi-
ture in comparison to loxTB MC4R mice,
which exhibited a phenotype identical to
global MC4R null mice. Comparable
changes were not observed when MC
signaling was reconstituted in the auto-
nomic brainstem neurons only. The
authors therefore concluded that the
lowered body weight and elevated energy
expenditure resulted from re-expression
in sympathetic motor neurons. Interest-
ingly, reactivation of MC4R signaling
in cholinergic neurons also improved
hyperinsulinemia and hyperglycemia,
while re-expression of MC4R selectively
in brainstem neurons only improved hy-
perinsulinemia. Specifically, they found
improved efficiency of insulin-induced
inhibition of hepatic glucose production
following general re-expression of MC4R
in cholinergic neurons, but not with
specific re-expression in the vagal motor
neurons. These observations nicely fit
with previous data (van den Hoek et al.,
2008), and indicate that the activity of
the sympathetic input to the liver is
balanced by the NPY- and POMC-con-
taining projections from the arcuate
nucleus. An increased NPY input toCell Metabolism 13sympathetic preautonomic hypothalamic
neurons reduces hepatic insulin sensi-
tivity, whereas a reinstatement of MC
signaling (derived from the arcuate
nucleus) onto sympathetic preganglionic
neurons in the spinal cord increases
hepatic insulin sensitivity (Rossi et al.,
2011).
The current study clarifies the important
roleof theMC4Rasamodulatorof theANS
and thereby of energy expenditure and
glucose homeostasis. Previous studies of
the same team using reactivation of
MC4Rs in the PVN and part of the amyg-
dala showed a clear rescue of the hyper-
phagia in MC4R null mice (Balthasar
et al., 2005). Together, these studies reveal
a highly differentiated manner in which the
MC4R contributes to energy metabolism.
This alerts us that when considering thera-
peutics, we should not concentrate on one
hormone,peptide, receptor, and soon,but
also take into account their specific
targets—i.e., the anatomical location. A
major future challenge is whether it is
possible to further restrict MC4R expres-
sion to subpopulations of neurons con-
nected to specific organs or tissues, or
from the point of pharmacological inter-
vention, whether it is possible to stimulate
energy expenditure and insulin sensitivity,
without causing side effects on heart rate
and blood pressure.
As with any scientific approach, there
are pitfalls and shortcomings. For
example, the knock-in of a targeted gene
in a specific cell population using the Cre-
lox system is only as specific as the
promoter used and only meaningful if the
Cre mouse is specific for, completely ex-
pressed in, and limited to, all of those
target cells. As with all nonconditional
models, compensatory changes during, February 2, 2011 ª2011 Elsevier Inc. 121
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Figure 1. Genetic Dissection of CNS Metabolic Control: Functional Neuroanatomy Linking Cholinergic and Melanocortin Systems
(A–D) Both the cholinergic (Woolf, 1991) and MC4R system (Liu et al., 2003) are globally distributed from forebrain to hindbrain (A). In the study of Rossi et al.,
MC4R is re-expressed either in all cholinergic neurons (B), or specifically re-expressed in brainstem autonomic control neurons (C). In the study of Balthasar
et al., MC4R was re-expressed in noncholinergic neurons in the hypothalamic paraventricular nuclei (PVN) and the amygdala in limbic cortex (D). Reinstatement
of MC4R signaling in PVN and amygdala mainly affected feeding behavior, reinstatement of MC4R in parasympathetic preganglionic neurons is probably respon-
sible for the control of circulating insulin level, and reinstatement of MC4R in preganglionic sympathetic neurons is most likely involved in the regulation of hepatic
insulin sentivity and energy expenditure. Amb: nucleus ambiguous; BAS: nuclei basalis and ventral globus pallidus; BST: bed nucleus of the stria terminalis;
CNNs: cranial nerves nuclei; DMH: dorsomedial hypothalamus; HIP: hippocampus; IL: infralimbic cortex; IML: intermediolateral column; IP: interpeduncular
nucleus, LDT: laterodorsal tegmental; LOT: nucleus of the lateral olfactory tract; LPB: lateral parabrachial nuclei; MPT: medial pretectal nucleus; MS and DB:
medial septal nucleus and diagonal band; NTS: nucleus of solitary tract; PAG: periaqueductal gray; PPT: pedunculopontine tegmental; SFO: subfornical organ;
Tu: olfactory tubercle; VMPO: ventromedial preoptic area.
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current study, it is unclear, in the general
knockin, what the contribution is of the
re-expression of MC4R in the acetylcho-
line containing neurons in the arcuate, the
laterodorsal tegmental (LDT), and the pe-
dunculopontine tegmental (PPT) nucleus
to the phenotype observed.
Howdo the current findings of an impor-
tant role for sympathetic activity in the
control of hepatic glucose production
relate to the findings of Pocai et al. (2005)
that claim a key role for vagal activity in
the control of hepatic glucose production?
Whereare themelanocortins thataffect the
MC4R on the preganglionic neurons in the
brainstem and spinal cord coming from?
What is the significance of the ectopic
expression of MC4R in the forebrain
acetylcholine neurons that provide such
a massive input to the cortex? Additional122 Cell Metabolism 13, February 2, 2011 ª2questions relate to the specificity of the
currently observed effects on glucose
metabolism as well. MC4R-KO mice
display hepatic steatosis, whereas activa-
tion of theMC system reduces the expres-
sion of lipogenic genes in the liver.
Recently, it was discovered that the CNS
MC system directly controls circulating
HDL cholesterol (Perez-Tilve et al., 2010)
and triglyceride metabolism in liver and
adipose tissue (Nogueiras et al., 2007).
Identification of the responsible MC4R
subpopulation would be important and
might allow for development of more
specific therapeutics.
In conclusion, the story of which Claude
Bernard started and which Rossi and
colleagues so elegantly continued is far
from over. We now know that hepatocytes
respond to MC signaling in the autonomic
nervous system. But in order to develop011 Elsevier Inc.a sound treatment for the metabolic
disease epidemic we are facing today,
we need to find a way to orchestrate all
tissues to receive their tailored balance of
sympathetic and parasympathetic tones.REFERENCES
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Adiponectin and its receptors, AdipoR1 and AdipoR2, regulate glucose and fatty acid metabolism partly via
activation of AMP-activated protein kinase (AMPK). Recent work in Nature Medicine (Holland et al., 2011)
suggests that adiponectin stimulates ceramidase activity through AdipoR1 and AdipoR2, an activity poten-
tially involved in promoting cell survival.Adiponectin is a major insulin-sensitizing
adipokine (Berg et al., 2001; Fruebis
et al., 2001; Yamauchi et al., 2001). Adipo-
nectin levels are decreased in cases of
obesity and type 2 diabetes, a finding
that has attracted enormous interest in
the scientific community. Adiponectin
stimulates AMP-activated protein kinase
(AMPK), and this action has been impli-
cated in its insulin-sensitizing function in
liver and muscle (Yamauchi et al., 2002;
Nawrocki et al., 2006). Both adiponectin
receptors, AdipoR1 andAdipoR2 (Yamau-
chi et al., 2003), mediate the major part of
the insulin-sensitizing action of adiponec-
tin in liver, while AdipoR1 primarily does
so inmuscle (Yamauchi et al., 2007; Iwabu
et al., 2010). Although it was previously
shown thatAdipoR1andAdipoR2 regulate
glucose and fatty acid metabolism partly
via activation of AMPK, Ca2+, and PPARa
signaling pathways, it was not known
whether these signaling pathways are
sufficient to explain the pleiotropic actions
of adiponectin. This study adds ceramide
signaling as a new pathway involved in
mediating such pleiotropic effects.
Scherer and colleagues also confirm
that adiponectin ameliorates insulin resis-
tance induced by a high-fat diet (HFD)
in an AdipoR1- or AdipoR2-dependent
fashion (Holland et al., 2011). Interest-ingly, they demonstrate that adiponectin
lowers cellular ceramide levels via acti-
vation of ceramidase, which converts
ceramide to sphingosine, an effect that
appears to be dependent on activation
of AdipoR1 or AdipoR2. They found that
in liver, overexpression of adiponectin,
AdipoR1, or AdipoR2 reduces hepatic
ceramide levels and improves insulin
sensitivity, while deficiency of adiponectin
increases hepatic ceramide levels and
exacerbates insulin resistance. Because
increased ceramide levels correlate with
impaired insulin action in muscle (Savage
et al., 2007), it is tempting to speculate
that the relationship between adiponec-
tin-induced changes in ceramide levels
and those in insulin sensitivity may be
causal; this hypothesis should be exam-
ined experimentally.
Accumulation of ceramide has also
been implicated in both b cell decompen-
sation and heart failure induced by a HFD.
This may be due to reduced ceramidase
activity associated with reduced sphingo-
sine, leading to reduced sphingosine
1-phosphate (S1P), a potent inhibitor of
apoptosis generated via phosphorylation
of sphingosine by sphingosine kinase.
Scherer and colleagues use their elegant
model of conditionally induced apoptosis
to demonstrate that adiponectin both in-creases S1P and protects from apoptotic
cell death induced by either palmitate or
C2-ceramide in cardiac myocytes and
pancreatic b cells (Holland et al., 2011).
Because this protection is reversed by
either an inhibitor of ceramide biosyn-
thesis or S1P itself, it seems likely that adi-
ponectin-induced S1P generation pro-
tects cardiac myocytes and b cells from
cell death.
In this study, adiponectin significantly
reducedhepaticceramide levelsandblood
glucose levels inmice deficient in LKB1, an
upstream activator of AMPK, which had
increased basal hepatic ceramide levels
and blood glucose levels compared to
controls (Holland et al., 2011). From these
data, they argue that adiponectin reduces
hepatic ceramide levels independent of
AMPK. No evidence yet exists to support
this claim, as it may be difficult to draw
a conclusion on the role of AMPK per se
in decreasing glucose levels or on the role
of adiponectin on lowering ceramide in
this system. Moreover, the activation of
AMPK and Ca2+ signaling pathways
occurs within minutes after adiponectin
stimulation, whereas activation of cerami-
dase appears to occur within a half hour,
raising some question of whether cerami-
dase is the most upstream event following
AdipoR1 or AdipoR2 activation., February 2, 2011 ª2011 Elsevier Inc. 123
